Status:
COMPLETED
Symbicort Onset of Action 2
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma
Eligibility Criteria
Inclusion
- At least 18 years of age
- Diagnosis of asthma and baseline lung function test results as determined by the protocol
- Required and received inhaled corticosteroids within timeframe and doses specified in the protocol
Exclusion
- Severe asthma or asthma that is markedly effected by seasonal factors
- Has required and received non-inhaled corticosteroids within the previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with beta-blockers
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2003
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00646009
Start Date
March 1 2003
End Date
August 1 2003
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.